DEV Study

DEV Study, Type 2 Diabetes

Objective

Actively Recruiting Study

DEV Study, Type 2 Diabetes

The DEV study is recruiting participants between the ages of 50 and 70 with a Diagnosis of Type 2 Diabetes OR a hemoglobin A1C > 6.5% within the past 24 months. Any duration of diabetes and any treatment regimen is acceptable. Patients will be administered FitBits for 6 months and provide blood, stool, and cheek swab samples. Data collected from this study will be used to improve diagnosis of T2D transitions.

Clinical Trial Categories

• Type 2 Diabetes

Sponsor(s)

Phenome Health

How to Participate

For more information please email

khamoudeh@newbridgehealth.org

Contact me